EARNINGS (LOSS) PER SHARE (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Per Share [Abstract]
Net income (loss) attributable to Valeant Pharmaceuticals International, Inc.	$ 275.4	$ (973.2)	$ 378.6	$ (989.9)
Basic weighted-average number of common shares outstanding	335.4	333.6	335.2	316.5
Diluted effect of stock options and RSUs (in shares)	5.9	0	6.2	0
Diluted weighted-average number of common shares outstanding	341.3	333.6	341.4	316.5
Earnings (loss) per share attributable to Valeant Pharmaceuticals International, Inc.:
Basic (in dollars per share)	$ 0.82	$ (2.92)	$ 1.13	$ (3.13)
Diluted (in dollars per share)	$ 0.81	$ (2.92)	$ 1.11	$ (3.13)